PRESS RELEASE Alexandria, Va., Jan. 29, 2015 —The Academy of Managed Care Pharmacy applauds two crucial provisions in draft legislation issued this week by the home Energy and Commerce Committee that combat the abuse of controlled substances and payment fraud in the Medicare Part D prescription drug benefit program. AMCP CEO Edith A. Rosato, RPh, IOM issued the following declaration: The Academy is pleased the Committee’s costs includes Sec. 4281, which calls for creating safe pharmacy systems in Part D to prevent the diversion and abuse of controlled chemicals, and Sec. 4282, which authorizes Part D programs to suspend payment of promises to pharmacies suspected of a credible allegation of fraud.Medical school deans, department chair, division chiefs, and training curriculum directors from in the united states will take part in the summit to greatly help ASN identify the best methods to solving this long term shortage of kidney experts. ‘We are distressed by the growing evidence of an upcoming crisis in the amount of kidney doctors necessary to meet the demands of the an incredible number of patients with kidney disease,’ stated ASN President Sharon Anderson, MD, FASN. ‘We believe this summit is an important first step to making certain the millions who have problems with kidney disease continue to receive timely, high-quality care and that kidney analysis continues to progress our ability to address this growing epidemic.’ ASN Renal Week 2010, the biggest nephrology conference of its kind, provides a forum for 13,000 specialists to discuss the most recent findings in renal research and engage in educational sessions related to advancements in the treatment of sufferers with kidney and related disorders.